pharmabiz.com
Medical experts see rising incidence of colorectal diseases in modern lifestyles
If you have IBD or are at risk for colorectal disease, clinicians at the conference highlighted that these conditions are being seen more often and that treatment approaches have shifted toward personalized medicine and biologic therapies.
Adults with IBD or colorectal cancer risk, clinicians and surgeons, and caregivers interested in up-to-date treatment approaches.
What To Know
Doctors at a regional surgical gastroenterology conference in India reported rising rates of colorectal diseases — including colorectal cancer, inflammatory bowel disease (IBD), and Crohn’s disease — and discussed how treatments have changed.
The speakers said colorectal cancer care has become more personalized with tumor genetic testing to guide targeted drugs, and that IBD management has shifted from frequent steroid use and surgery toward biologic therapies (monoclonal antibodies) that can reduce the need for operations.
The article summarizes conference remarks and emphasizes continuing medical education for clinicians to stay current. What this does not tell us: The piece is a conference report and does not provide new study data, specific drug names or trial results beyond general statements, nor patient-level outcomes.
It also does not quantify the rise in disease incidence.
This is a news report of expert commentary at a medical conference rather than a research study. Statements reflect clinicians' perspectives and descriptions of evolving treatment options; it is not new clinical-trial evidence and does not list specific data or comparative outcomes.
